Selected Publications

Melina E Marmarelis 1 2, Dylan G Scholes 1 3, Tara L McWilliams 4 5, Wei-Ting Hwang 2 4 5, John Kosteva 1, Michael R Costello 1, Lova Sun 1 2, Aditi P Singh 1 2, Kelsey S Lau-Min 6, Abigail Doucette 2 3, Peter E Gabriel 2 3 7, Anthony O Martella 3, Megan A Roy 1 2, Jeffrey C Thompson 2 8, Roger B Cohen 1 2, David W Dougherty 1 2, Lawrence N Shulman 1 2 3, Corey J Langer 1 2, Justin E Bekelman 2 3 7, Erica L Carpenter 1 2, Charu Aggarwal 1 2 3: Electronic Medical Record-Based Nudge Intervention to Increase Comprehensive Molecular Genotyping in Patients With Metastatic Non-Small Cell Lung Cancer: Results From a Prospective Clinical Trial. JCO Oncol Pract 20(12), Dec 2024.

Jacob B Reibel 1, Lova L Sun 1, Ravi B Parikh 1 2, Nadim Mahmud 3 4, Lainie P Martin 1, Rebecca A Hubbard 5, Ronac Mamtani 1: Real-world impact of the platinum chemotherapy shortage on US patients with advanced cancer. J Natl Cancer Inst Dec 2024.

Connor B Grady 1, Wei-Ting Hwang 1, Joshua E Reuss 2, Wade Iams 3, Amanda Cass 3, Geoffrey Liu 4, Devalben Patel 4, Stephen V Liu 2, Gabriela Liliana Bravo Montenegro 2, Tejas Patil 5, Jorge J Nieva 6, Amanda Herrmann 6, Kristen A Marrone 7, Vincent K Lam 7, William Schwartzman 8, Jonathan Dowell 8, Liza C Villaruz 9, Kelsey Leigh Miller 10, Jared Weiss 10, Fangdi Sun 11, Vamsidhar Velcheti 12, D Ross Camidge 5, Charu Aggarwal 13, Lova Sun 13, Melina E Marmarelis 13: Determining Line of Therapy from Real-World Data in Non-Small Cell Lung Cancer. Pharmacoepidemiol Drug Saf 33(12), Dec 2024.

Glenn J Hanna 1, Jamie Jabalee 2, John N Lukens 3, Lova Sun 3, Eleni M Rettig 4, Rocco Ferrandino 2nd 5, Marshall R Posner 5, Krzysztof J Misiukiewicz 5, David M Routman 6, Kathryn M Van Abel 6, Catherine Del Vecchio Fitz 2, Scott A Roof 5: Circulating tumor tissue modified viral (TTMV)-HPV DNA in Recurrent, metastatic HPV-driven oropharyngeal cancer. Oral Oncol 158, Nov 2024.

Elghawy O, Barsouk A, Xu J, Chen S, Cohen RB, Sun L.: Real word outcomes of cabozantinib therapy in poorly differentiated thyroid carcinoma. Eur Thyroid J Nov 2024.

Omar Elghawy 1, Adam Barsouk 1, Jessica Xu 1, Simon Chen 2, Roger B Cohen 1, Lova Sun 1: Real word outcomes of cabozantinib therapy in poorly differentiated thyroid carcinoma. Eur Thyroid J 13(6), Nov 2024.

Lova Sun 1, Roger B Cohen 2, A Dimitrios Colevas 3: Platinum/taxane/pembrolizumab vs platinum/5FU/pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma (r/m HNSCC). Oral Oncol 158, Nov 2024.

Aman M Patel 1, Afash Haleem 1, Lucy Revercomb 1, Jason A Brant 2 3, Karthik Rajasekaran 2, Lova L Sun 4, Robert M Brody 2 3, Ryan M Carey 2 3: Primary site surgical resection in cM1 oral cavity squamous cell carcinoma. Laryngoscope Investig Otolaryngol 9(5), Oct 2024.

Elghawy O, Barsouk A, Heidlauf A, Chen S, Cohen RB, Sun L.: Single-Institution Experience of Larotrectinib Therapy for Patients With NTRK Fusion-Positive Thyroid Carcinoma. J Endocr Soc 8: bvae158, Sep 2024.

Adam Barsouk 1, Omar Elghawy 2, Alec Heidlauf 3, Connie Yu 3, Lucy Wang 3, David Yang 3, Martin Kurian 3, Keshav Goel 3, Lynn Rushkin 3, Anna Anran Huang 3, Lauren Reed-Guy 2, Benjamin Bleiberg 2, Lova Sun 2, Aditi Singh 2, Roger B Cohen 2, Charu Aggarwal 2, Melina Marmarelis 2, Corey Langer 2: Real-world outcomes of atypical EGFR-mutated metastatic non-small cell lung cancer (mNSCLC) treated with osimertinib (osi) vs. Afatinib or erlotinib. Lung Cancer 195, Sept 2024.